The US launches the first weight-loss pill in thirteen years. Arena Pharmaceutical's Belviq can be used by obese or overweight people under the condition they have a body mass index of 30 or higher.
The pill, which helped participants in a medical research lose on average five percent of their body weight, was rejected in 2010 due to concerns over tumors that developed in animals tested with the drug.
In June 2012, the pill was approved by the US Food and Drug Administration. It is designed to block appetite signals in the brain, making patients eat less but feel fuller.
Known side effects of the pill include depression, migraine and memory lapses.
The calendar you're trying to add has already been added to this event.
This is not a valid number
You are about to leave this page. Any changes you made will not be saved.
Are you sure?
What kind of event would you like to create?